In recent years, more and more manufacturers and operators of fleets of mobile systems have been focusing their efforts on studying and developing conditional maintenance, monitoring, and diagnostic strategies to cope with an increasingly competitive, unstable, costly, and unpredictable environment. This paper proposes a case study concerning the application of a novel event management architecture, called EMH 2 , to a fleet of trains. This EMH 2 architecture, which applies the holonic paradigm, aims to facilitate the monitoring and diagnosis of a fleet of mobile systems. It is based on a recursive decomposition of cooperative monitoring holons. The definition of a generic event modeling, called SurfEvent, is the second key element of the contribution. EMH 2 has been designed to be applicable to any kind of system or equipment up to fleet level. The edge computing paradigm has been adopted for implementation purpose. The EMH 2 architecture is designed to facilitate asynchronous and progressive onboard and off-board deployments. A realworld application of EMH 2 to a fleet of ten trains currently in use, in collaboration with our industrial partner, Bombardier Transport, is presented. Three key performances indicators have been estimated by comparing EMH 2 with the current industrial situation. These indicators are (1) the number of fleet maintenance visits, (2) the time needed by a maintenance operator to investigate and diagnose, and (3) the time needed by the system to update data regarding the health status and monitoring of trains. Results obtained outperformed industrial expectations. The paper finally discusses feedbacks from experience and limitations of the work.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.